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Abstract
Background: In the regulation of healthcare, the subject of patient and family involvement figures increasingly
prominently on the agenda. However, the literature on involving patients and families in regulation is still in its
infancy. A systematic analysis of how patient and family involvement in regulation is accomplished across different
health systems is lacking. We provide such an overview by mapping and classifying methods of patient and family
involvement in regulatory practice in four countries; Norway, England, the Netherlands, and Australia. We thus
provide a knowledge base that enables discussions about possible types of involvement, and advantages and
difficulties of involvement encountered in practice.
Methods: The research design was a multiple case study of patient and family involvement in regulation in four
countries. The authors collected 1) academic literature if available and 2) documents of regulators that describe user
involvement. Based on the data collected, the authors from each country completed a pre-agreed template to
describe the involvement methods. The following information was extracted and included where available: 1)
Method of involvement, 2) Type of regulatory activity, 3) Purpose of involvement, 4) Who is involved and 5) Lessons
learnt.
Results: Our mapping of involvement strategies showed a range of methods being used in regulation, which we
classified into four categories: individual proactive, individual reactive, collective proactive, and collective reactive
methods. Reported advantages included: increased quality of regulation, increased legitimacy, perceived justice for
those affected, and empowerment. Difficulties were also reported concerning: how to incorporate the input of
users in decisions, the fact that not all users want to be involved, time and costs required, organizational
procedures standing in the way of involvement, and dealing with emotions.
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Conclusions: Our mapping of user involvement strategies establishes a broad variety of ways to involve patients
and families. The four categories can serve as inspiration to regulators in healthcare. The paper shows that
stimulating involvement in regulation is a challenging and complex task. The fact that regulators are experimenting
with different methods can be viewed positively in this regard.
Keywords: Patient involvement, Family involvement, Healthcare regulation, Participation, Decision-making, Norway,
England, the Netherlands, Australia
Background
In many countries, patient and family involvement is
high on the health policy agenda. Efforts to increase in-
volvement can be seen at multiple levels of decision-
making: the individual, the organizational and the policy
level. The rationale for involving patients and families is
two-fold. First, the expectation is that it will lead to bet-
ter quality decisions across levels and thereby to better
quality, and person-centred care. Second, as patients are
the ones affected by decisions, they should have the op-
portunity to influence decisions [1–8].
In the regulation of healthcare, the subject of patient
and family involvement also figures increasingly promin-
ently on the agenda [1, 9]. User involvement in regula-
tion can be varied in nature. It can include providing
individuals with information about a regulator; mobiliz-
ing users and patients as sources of information; and
reviewing whether health service providers involve users
in service delivery and planning [5, 6]. This means that,
on the one hand, involvement of patients and families is
incorporated in regulatory standards and expectations
directed at healthcare service providers [1, 5, 10–12]. On
the other hand, involvement figures increasingly in the
work of healthcare regulators themselves [5, 6, 13, 14].
In this paper, our main focus is on involvement initiated
by regulators, although we recognize that this is interre-
lated with regulatory standards addressing involvement
in service provision.
There is a growing literature on involving patients and
families in their own care, especially in service provision
[3, 4]. In comparison, the literature on involving patient
and families in regulation remains in its infancy [5].
There are exploratory studies reporting experiments
with involvement in different aspects of regulation, such
as including patients in inspection teams, theme-based
inspections, the investigation of sentinel events, using
them as mystery guests and involving patients and fam-
ilies in developing inspection assessment criteria [5, 6, 9,
12, 15–17]. However, despite these examples of specific
cases in the literature, a more systematic analysis of how
patient and family involvement in regulation is accom-
plished across different health systems is lacking.
In this paper, we provide such an overview by map-
ping and classifying methods of patient and family
involvement in regulatory practice in four countries;
Norway, England, the Netherlands, and Australia. We do
so by analyzing the literature and other relevant sources
such as the grey literature, websites, and documents of
regulators that describe user involvement. By mapping
methods of involvement and the use of patient and fam-
ily experiences in the regulation of healthcare organiza-
tions, we provide a knowledge base that enables
discussions about possible types of involvement, and ad-
vantages and difficulties of involvement, encountered in
practice. Such an analysis can help regulators, and also
shape the agenda for future research.
The following research questions guided our study:
1. What kind of methods for patient and family
involvement in regulatory practice do regulators use
in different countries?
2. What are the reported benefits and challenges of
involving patients and family members?
The paper proceeds as follows. First, we describe the
methods used in our study. Second, in the results section
we categorize and describe the methods of involvement
that we found in the selected countries and present
available evaluations of these. In the discussion, we re-
flect on our findings and relate them to the literature in
order to identify lessons learnt for involvement in regu-
lation, alongside topics for future research.
Methods
Research design and case selection
The research design was a multiple case study of patient
and family involvement in regulation in four countries.
A case was defined as a country and the methods identi-
fied for patient and family involvement in organizational
regulation of quality and safety in healthcare [18]. The
scope of our cases was limited to the regulation and
regulatory practice related to organizations such as hos-
pitals, nursing homes, youth care and home care. This
means that involvement in regulation of individual
healthcare professionals, such as involvement in deci-
sions on disciplining or striking off doctors and nurses
from their licenses and registries, was omitted. The regu-
latory bodies included in our country cases are the
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Norwegian Board of Health Supervision (NBHS) and
County Governors in Norway, the Care Quality Com-
mission (CQC) in England, and the Health and Youth
Care Inspectorate (HYCI) in the Netherlands. In
Australia, the Australian Commission on Safety and
Quality in Health Care (ACSQHC), which developed
that country’s accreditation standards, was included as
the key stakeholder in this particular regulatory system
(see Table 1 for details about the country regulatory
contexts and references to official web pages).
We aimed to sample a broad range of empirical mater-
ial from different nations and healthcare systems to illu-
minate the research questions from several angles [18,
28, 29]. We purposively selected countries with different
types of healthcare systems. Notwithstanding this, all are
high-income countries where one could expect a devel-
oped approach to user involvement at all system levels,
including the regulatory level. The rationale for conduct-
ing cross-country studies can be for comparative pur-
poses, however the main reason for our case selection
was not comparison, but rather to provide a broad-
ranging overview. Our case selection enabled access to
data on methods of involvement from a variety of con-
texts. This served as a basis for developing an overview
of existing methods and how countries approach user
involvement in regulation.
Data collection and analysis
The data collection was conducted between February
and April 2019 according to a template designed by the
authors centred on the research questions. The authors
based in each country collected 1) academic literature if
available and 2) documents of regulators that describe
user involvement. These documents included: grey lit-
erature, project reports, policy documents, and projects
conducted by healthcare regulatory bodies described on
their web pages. We felt it important to incorporate the
grey literature, as involvement projects in regulation are
often not designed as research projects, and therefore
not published in peer reviewed journals. We conducted
a broad search, as the main aim was to map existing
methods of involvement in addition to possible existing
evaluative data.
In each country the researchers identified relevant arti-
cles and reports based on their expertise of the subject.
In addition, they searched academic data bases such as
Medline, PubMed, Cinahl, and Google Scholar with
search words covering user involvement, patient partici-
pation, family involvement, regulation, supervision, in-
spection, healthcare, quality, quality improvement and
patient safety in combination with the names of the
countries. We used this approach to identify country
specific academic literature. In addition, the Norwegian
and the Dutch data collection covered relevant journals
in native language where native language search words
were used. To identify grey literature and information
on the web pages of each country’s regulatory body, the
researchers used similar search words as in the literature
searches. Moreover, some of the regulatory bodies had
gathered information about user involvement and pub-
lished reports on the topic on their web pages. This
helped the researchers to identify relevant projects and
reports. In addition, due to the limited literature identi-
fied in data bases, some of the research team used Twit-
ter to ask if someone knew of published papers or
reports covering the topic of patient and family involve-
ment in healthcare regulation or discussed this question
with experts in the field.
The authors from each country completed a pre-
agreed template to describe the involvement methods
found. The following information was extracted and in-
cluded if available: 1) Method of involvement, 2) Type of
regulatory activity, 3) Purpose of involvement, 4) Who is
involved, and 5) Lessons learnt. In addition, researchers
from each country provided a short description of their
regulatory system, the actors, and their roles and respon-
sibilities in order to provide contextual understanding of
the different healthcare systems from which the data
was collected.
During the data collection, questions from the re-
searchers were handled by authors SW and HvB, in
order to clarify and align the methodological approach
across the research team. The discussions were import-
ant to ensure a similar approach and trustworthiness of
the results. The completed templates were submitted to
authors SW and HvB who led the cross-country analysis.
During the cross-country analyses, results were synthe-
sized [30, 31], which enabled us to identify existing
methods of involvement, commonalities and differences,
and clusters of similar types of involvement activities.
In order to find a meaningful way to categorize the in-
volvement methods and to learn from the diversity and
similarities, the cross-country synthesis sought to
categorize involvement methods inspired by Tritter’s [1]
framework from two dimensions: individual vs collective,
and proactive vs reactive involvement. This synthesis re-
sulted in four categories of involvement methods, de-
scribed as 1) individual and proactive 2) individual and
reactive, 3) collective and proactive, and 4) collective
and reactive (see Tables 2, 3, 4 and 5). The results were
categorized as individual if they related to individual pa-
tients/user/family experiences with their own care in
specific situations. Results were categorized as collective
if they related to general aspects where involvement was
not related to a specific patient’s own case or treatment,
but those involved were expected to represent a group
of interests or inform regulatory inspectors on specific
topics based on their experiences. We categorized
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Table 1 Description of regulatory context per country
Country Description of regulatory context
England The supervision authority in England is the Care Quality Commission (CQC) [19]. CQC was established in 2009 as an
independent non-departmental body, which is at arm’s length from government ministers. The CQC is held accountable
to Parliament through the Health and Social Care Select Committee and to the Department of Health and Social Care
through quarterly accountability review meetings. The CQC has a unitary board with a majority of non-executive members,
which holds public and private meetings. The purpose of the CQC is to make sure health and social care services provide
people with safe, effective, compassionate, high-quality care and to encourage care to improve. The CQC regulates the
activities of health and social care organizations at almost 50,000 locations, serving the 55 million people in England. The
main functions of the CQC are:
• Register: Maintain a register of who is legally able to deliver regulated activities. Organizations are required to show they
can meet standards of care set out in regulations in order to join the register. Subsequently they must notify the CQC of
deaths and other incidents affecting service users, such as deaths not attributable to their illness, injuries, abuse, insufficient
staff, and interruption of basic services such as gas and electricity.
• Monitor, inspect and rate: Monitor the quality of care by gathering and analyzing data, including from people who use
services, providers and other stakeholders. Monitoring informs the inspection of services to make sure they are providing
care that is safe, effective, caring, responsive and well-led. Inspection findings are published, including for many services a
rating of the quality of care. The CQC protects people by taking enforcement action to address poor care.
• Independent voice: Publish reports on major national and regional quality topics, while also highlighting good practice.
The CQC does not routinely have a role in investigating adverse incidents or complaints. Healthwatch England, the national
consumer champion for users of health and social care services, is a statutory committee of the CQC’s Board. The CQC has
a duty in law to take account of the views and experiences of local Healthwatch.
(Source: [19])
The Netherlands The regulatory authority in the Netherlands is the Health and Youth Care Inspectorate (HYCI) (Inspectie voor de
Gezondheidszorg en Jeugd, IGJ) [20], which is part of the Ministry of Health, Welfare and Sport. This inspectorate
regulates and promotes good and safe care. It’s regulatory activities are partly risk-based, thematic and incident
based. The work of the inspectorate is based on different national acts focusing on, amongst others, quality of care
in different sectors and the governance thereof, individual professionals, complaint procedures, and medication safety.
One of the current focus points of the HYCI is person-centred care as it is considered an important condition for
providing good and safe care. The HYCI distinguishes between the perspective of the public and the patient. Including
both perspectives in its work is high on the regulatory agenda and mentioned specifically in multi-annual policy plans
of ‘16-‘19 and ‘20-‘23. A vision document ‘Public and patient’s perspective in regulation’ was also written. The HYCI
installed a Coordination Group Public and Patient Perspective in Regulation in May 2018 to collect information, advice
and coordinate activities aimed at stimulating the inclusion of the public and patients perspective in regulation.
The National Healthcare Report Centre, where citizens can ask questions and report complaints about the quality of care,
is part of HYCI.
In the Netherlands, healthcare organizations mostly conduct their own investigations in response to incidents. The HYCI
requires that they involve patients or family members in these investigations. In addition, the HYCI has conducted many
experiments to involve citizens in its inspections (more on this below). The HYCI works together with a number of
universities in an academic collaborative where research is conducted into all kinds of aspects of regulatory work. This
includes the subject of public/patient participation.
(Source: [20])
Australia Regulation of the Australian healthcare system is complex and fragmentary. Responsibilities are shared among a
network of national, six state and two territory departments of health, in addition to other government bodies [21].
Accreditation against standards is one of the major strategies for assuring the quality and safety of healthcare
organizations. Before the federal government became involved, Australian hospitals were early-adopters of this
approach, dating from the 1970s via the Australian Council on Healthcare Standards [22]. Accreditation was initially
a voluntary activity. Due to growing scrutiny of hospital adverse events in the 1990s, Australian states passed laws
mandating their hospitals take part in accreditation [23]. From 2000, the Council of Australian Governments passed
reforms that subsequently established the Australian Commission on Safety and Quality in Health Care (ACSQHC)
[24] and made accreditation against the national standards mandatory for all public and private hospitals [23]. However,
the accreditation of general practices is still voluntary [25], and national accreditation standards have only recently
been made mandatory for government subsidized residential aged care facilities [26].
Unlike other health systems discussed in this paper, in Australia, there is no national regulatory body conducting
inspections to ensure health services are delivered safely and according to the law. Rather, the National Safety and
Quality Health Service Standards, developed by the ACSQHC, are used by independent organizations who are
contracted by healthcare organizations to conduct their accreditation surveys, usually on a 3–4 yearly basis [24]. If
any of the standards are ‘not met’, hospitals have up to 3 months to resolve the issue, depending on the risks
associated with the issue. At state and territory levels, there are also departments of health, and a range of
commissions and divisions that play a role in monitoring and improving the quality and safety of healthcare
organizations, such as the Clinical Excellence Commission in New South Wales (Australia’s most populous state).
When a standard is not met during an accreditation survey, state and territory health departments are notified
and may take other regulatory action or provide support to health services as they address the issue [24].
(Source: [24–26])
Norway The supervision authorities are the Norwegian Board of Health Supervision (NBHS) (the central office), and the
Offices of the County Governors (regional offices). The NBHS [27] is a national public institution organized under
the Ministry of Health and Care Services. The overall aim of public supervision is to ensure that health and social
services are provided according to national acts and regulations. In Norway, there is comprehensive legislation
regarding child welfare, health and social services that:
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involvement as proactive if the involvement was about
collecting information or involving patients/users/fam-
ilies as part of planning future inspections, setting the
regulatory agenda or standards, or conducting routine,
planned inspections. We characterized results as reactive
if the involvement was related to follow up or handling
of issues, for example, adverse events, deviances from
standards or regulations, or complaints. The results of
this synthesis are presented in Tables 2, 3, 4 and 5.1 We
also analyzed the results in light of the reported benefits
and challenges present in the material.
All authors are experienced researchers in the field of
health services research, regulation, health policy and
user involvement. Among the authors, there are also
members with a background as regulatory inspectors
(SW) or in a current main position as members of an in-
spectorate (authors SK, SR) in addition to being re-
searchers. This experience in the author team was
beneficial in helping to identify important cases, chal-
lenges, possible literature, projects, and to suggest pos-
sible recommendations of relevance for both the
research community and for other regulatory bodies. In
England, a senior manager within the CQC was also
consulted, to ensure thoroughness in our search, and
clarification of the breadth of available involvement
methods.
Results
First, we present a short introduction to the regulatory
context of the four countries, before presenting the over-
all findings relating to involvement methods across
countries. We then describe the reported benefits and
challenges of involvement based on the evaluations, if
available, of experiments included in the study.
Regulatory context
In Table 1 we provide a brief overview of the regulatory
context of Norway, England, the Netherlands, and
Australia as a backdrop for this paper. Some countries
use the term regulation, while others use supervision or
inspection about their role and activity. This is reflected
in the context description in Table 1.
Methods of involvement in regulation across countries
The data synthesis identified a wide variety of methods
for user involvement in regulatory practice. In the fol-
lowing, we present the four categories of activities within
these. A summary of these results per country can be
found in Tables 2, 3, 4 and 5. (To ease readability of Ta-
bles 2, 3, 4 and 5 and the four involvement methods cat-
egories, we present this text without references. All
references are included when we present the reported
benefits and difficulties of involvement identified in re-
search studies or in the published grey literature).
Individual proactive methods of involvement
Individual proactive methods refer to involvement of in-
dividuals with the purpose of collaboration and use of
information for setting the future regulatory agenda and
planning regulatory activities. The results in this cat-
egory showed that the regulators in Norway, England,
and Australia used some kind of patient and user sur-
veys to collect information as part of setting the regula-
tory agenda and informing inspection activities. National
surveys are a way of collecting information about experi-
ences and outcomes of the health services from broad
groups of patients and users. We also identified more
targeted surveys. In such cases, surveys were designed
for specific groups, such as next of kin, and used to in-
form future system audits and make these more context-
specific and relevant for the target group of regulation
(e.g., children). Questionnaires were also utilized as part
Table 1 Description of regulatory context per country (Continued)
Country Description of regulatory context
• constitute requirements about the services that shall be offered to the population;
• constitute requirements about the quality of services;
• regulate the work of health care personnel who have authorization;
• give users of the services rights, for example, according to the Patients’ Rights Act.
Supervision applies to all statutory services, irrespective of whether they are provided by
municipalities, private businesses, publicly owned hospitals or health care personnel who
run their own practice.
Regulatory activities vary from area surveillance, proactive and planned supervision, and
reactive event based after adverse events or deficiencies in services.
At the level of the counties, supervision is carried out by the Offices of the County Governors.
The NBHS has a special Department that can conduct onsite inspections in cases of the most
severe adverse events. Most inspection activities are conducted by the Offices of County Governors.
(Source: [27])
1The Tables 2, 3, 4 and 5 may be empty or sparse because of how
regulation and governance of healthcare is organized. For example, in
England, one reactive category in the country table is empty because
CQC does not routinely have a role in investigating adverse incidents,
and most complaints are handled by other organizations. We would
also note that analyses of complaints and incident reports occur at
various levels, but not necessarily as a direct response or mechanism of
regulatory agencies, or with patients and families involved.
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of a regulatory activity to collect information from a
broader audience of users in planned inspections.
The regulators also made use of qualitative methods such
as individual interviews and meetings with service users. Reg-
ulators spoke with children, adolescents, parents, families,
next of kin, social and mental healthcare users, disabled
users, and frail older service users. We found these methods
were part of planned inspections (not initiated due to an ad-
verse event) in Norway, England, and the Netherlands. Regu-
lators collected information based on users’ experiences with
the services and used this information to assess if services
were provided according to standards and regulation.
Table 3 England
Individual/proactive Collective/proactive
• Patients share experience with services in an online form to CQC
• Annual user surveys to collect user experiences of particular service
of interest
• Inspectors and Experts by Experience speak with children, young
people, parents, families, and carers during inspections.
• National surveys
• CQC commission community groups and charities to collect user
experiences of particular pathways or types of care
• CQC carries out research and focus groups to collect user
experiences of particular pathways or types of care
• Awareness campaign using social media, digital marketing, charity
communications channels and other CQC communication channels
to encourage patients and families to share their experiences with CQC
• Collaboration with national charities to collect information about user
experiences via their helplines
• Collaboration with Healthwatch to produce guidance for local
Healthwatch and Inspectors on working with CQC to promote
involvement in reviews, on a general basis, and encourage members
to submit user experiences to CQC
• Public online community for involvement in health policy and service
design – includes both paid vouchers and self-selected groups
• Experts-by-experience involvement in thematic reviews (involvement
varies depending on topic)
• Expert advisory group set up as part of inspection approach - including
experts-by-experience members
• Establish user panels and advisory groups (children, mental health)
• Experts-by-experience used for speaking to people using services,
families and organizations, that support them
• Experts-by-experience assist in registration, thematic reviews, local
systems reviews, co-production, advisory groups, promotion of CQC
work, and training of inspectors
• Co-production of events by seldom heard communities
• “Mystery shoppers” and hidden cameras – CQC has considered
this approach but has decided not to conduct covert surveillance
• User panels (mental health, children and young)
• Commissioned research with users
• Data sharing partnership with other websites collecting intelligence
from users
Individual/reactive Collective/reactive
• Analyses of complaints and concerns from various sources as part of
its risk-based supervision of providers, called “intelligent monitoring”
Table 2 Norway
Individual/proactive Collective/proactive
• Interview with young social care users to inform system audit
• Interview with disabled users to inform system audit
• Questionnaire to next of kin to inform system audit
• Questionnaire to young service users in system audit
• Meeting with next of kin to inform system audit
• Interviews with service users during system audit
• Develop digital tool for communication with children
under 13 in child protection services
• Including interpreter in system audit of under aged refugees
in child protective service institutions
• Patient and user panel established for the regulatory body over
time to inform all regulatory activity (national and regional level)
• Next of kin as co-investigators in system audit
• User involvement in inspection team
• Organize seminars with adolescent user organization to inform
system audit of child protective services
• Develop national regulatory recommendations for user
involvement in regulatory practice
• Organize co-investigator experience workshop
Individual/reactive Collective/reactive
• Meeting between inspectors and next of kin in investigation of deaths
• Regulator organizes meeting with patient and healthcare professionals
in complaints cases or investigation of adverse events
• Regulated right for patient/family to a meeting with service provider
after a severe adverse event/death
• Regulator contacts/consults with next of kin, informs about the
process of investigation of the most severe adverse events conducted
at the national level inspectorate investigation unit
• Patient and user complaints can be sent to regulator
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The synthesis identified specific efforts among the
regulators to involve and get in contact with vul-
nerable groups with increased risk of not being
heard through routine approaches. For example, in
some Australian states, surveys are specifically di-
rected at ‘hard to reach’ groups (with low response
rates, however). In other countries, hard to reach
groups such as young asylum seekers, young people
with autism, people with a migrant background,
elderly and people with learning disabilities are tar-
geted through qualitative methods. Such methods
included the development of digital tools for com-
munication with children under 13, and experi-
menting with including interpreters in system




• Patient survey at the state level about recent experiences
and outcome of care
• REACH – Recognize, Engage, Act, Call, Help is on its way: state
initiative to empower consumers to ‘speak up for safety’, engage
with their nurses or medical team, and request clinical review
within 30 min
• Consumers members of clinical governance committees
• Involvement of consumers in accreditation standard development
• Accreditation standard requires healthcare organizations to partner
with consumers in planning, designing, measuring, delivery and
evaluation of care
• Co-surveyors where consumer are involved in the accreditation
process as team members
• Consumer involvement in regulation of healthcare research –
2 members are laypersons in all Human Research Ethics committees
• Collaborative Pair Program – National program to promote meeting
of accreditation standards requiring patient and consumer involvement.
Support clinician-patient approaches.
Individual/reactive Collective/reactive
• Regulatory requirement for investigation most severe adverse
events by a formal root cause analysis (RCA). Interviews with
patients and next of kin may be part of the RCA.
◦ Apology to patient and family as part of open disclosure in
RCA process
• Consumer, patients, families can submit complaints to ombudsman
Table 4 The Netherlands
Individual/proactive Collective/proactive
• Interview patients or family during planned inspections in
all care sectors
• Collect experiences from adolescents and other patient groups
(such as people living in poverty) in theme based inspections
• Interview frail older service users to inform theme based inspection
• Search social media to collect information from individual patients
as signals in risk based supervision
• User panels on specific regulatory topics
• User involvement in multi annual policy plan
• Advisory board of children (Children’s Council)
• User involvement in designing supervision frameworks
• Sharing information about the inspectorate to the public
• Use patients as a source of information for planning and
conducting theme based inspections
• Interview adolescents represented in a youth council as part
of theme based inspection
• Young peer-inspectors in inspection team to interview young people
• Experts-by-experiences (with learning disabilities) involved in the
entire inspection process of theme based inspection
• Experts-by-experience were trained and involved in inspections in
elderly care homes
• Mystery-guests with learning disabilities used in review of access of
services (experts by experience show up in institutions under-cover
and inform inspectors about their experiences)
• Mystery guests used in reviews of elderly home care
• Search social media to collect information about organizations as
signal in risk based supervision
• The ratings and reviews of an independent patient rating website




• Regulatory requirement for involvement of patient/next of
kin in incident investigation
• Contact next of kin after sentinel events to identify if they
have been involved in the required investigation by the
healthcare organization
• Inspecting of how healthcare organizations involve patient and next of
kin in incident investigation
• Aggregated information from complaints on sector and themes is used
in risk based supervision for agenda setting and prioritization
• Text mining research is performed to find relevant topics in complaints
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Individual reactive methods of involvement
Individual reactive methods of involvement refer to how
regulators involve individuals (patient, user, or next of
kin), when they have experienced either an adverse event
or filed a complaint about the service provision to the
regulator. The Netherlands, Australia and Norway have
regulation enabling users, or next of kin, to file com-
plaints to the regulator or an ombudsman, or both. This
legal right is one way of involvement in itself, but we
also sought to identify if, and how, people were involved
in the regulatory process after filing a formal complaint.
In the included countries, a complaint can relate to both
lack of service provision and being denied a service. In
addition, complaints can include reporting experiences
of adverse events, near misses, or patient harm. We
found examples from Norway where the regulator estab-
lished meeting arenas between regulatory inspectors,
service providers, and users or next of kin. The purpose
was to gather the involved parties and through a
dialogue-based approach, try to solve each complaint
case so it did not proceed to a formal and often long-
lasting written information exchange process between
the parties before reaching a conclusion.
In this category, we also found methods of involvement
in the regulatory investigation of adverse events. A regula-
tory investigation may be initiated based on patient com-
plaints, or by mandatory reporting of adverse events from
the service providers to the regulator. In Norway, results
showed several examples of individual involvement
methods in the investigation process. In the most severe
cases (e.g., deaths), investigated by the NBHS at the na-
tional level, the regulator always consults with the family,
informs them about the progress and collects their views
on the event. Moreover, there were examples at the
county level in Norway of regulators organizing formal
face-to-face meetings between regulatory inspectors and
next of kin to collect information about the adverse event
leading to patient death from the next of kin’s perspective.
In the Netherlands and Australia, we identified regulatory
requirements for service providers to conduct investiga-
tions of adverse events, but the regulator does not usually
investigate these. However, since both countries require
service providers to involve patients and the families in
the investigations, this implies that one way of prompting
user involvement is by regulating and requiring the service
providers themselves to involve patients and family in
investigations (as described in the introduction of this
paper). In addition, Norway has recently made it
mandatory for health service providers to invite patients
and users to a meeting after a severe adverse event. In
addition, in long-term care, the Dutch inspectorate experi-
ments with checking directly with next of kin whether the
service provider has involved them in the investigation
process.
Collective proactive methods of involvement
In collective proactive methods of involvement, the in-
volvement is not so much focused on a patient’s specific
case or treatment, but more generally. Users involved
are expected to represent a group of interests. The pur-
pose is to inform the future regulatory agenda or specific
inspections. The collective and proactive methods of in-
volvement demonstrated a wide repertoire in all the in-
cluded countries. England and the Netherlands were at
the forefront in utilizing a range of approaches. Methods
identified in this category related to involvement of user
panels and user organizations, campaigns, expert-by-
experience and mystery guests, data sharing, and
commissioning of research.
Across countries, the most common method of this
type is using experts-by-experience, peer-inspectors (in
inspection processes) or co-surveyors (in accreditation
processes). These methods consider users, patients and
family members to be experts on care, which warrants
them being a part of planned inspection activities (or ac-
creditation surveys in Australia). The degree of involve-
ment varied from being involved in an inspection
planning meeting, to being part of the inspection team
as co-investigator on site and in the analysis of results.
Experts-by-experience were reported to be involved in
thematic reviews and system audits. We identified varia-
tions on the expert-by-experience approach in different
fields. Examples included adolescents involved in the in-
spection team to interview adolescents in thematic in-
spections, co-designing regulatory frameworks, or
involvement of people with learning disabilities and next
of kin in an investigation process. Moreover, the synthe-
sis uncovered examples of older people being trained
and included in the inspection process in elderly care
homes. Similarly, the “mystery guest” method was ap-
plied in the Netherlands. Mystery guests are a subset of
the experts-by-experience approach, where potential ser-
vice users visited service providers “undercover” and
evaluated aspects of the services given. For example,
people with learning disabilities assessed the accessibility
of services as mystery guests. Another example of the
ways in which mystery guests were used, was consider-
ing whether the information they received from the ser-
vice provider would be easy to understand for the group
they represented. Based on these experiences the people
with learning disabilities, service providers and inspec-
tors discussed the accessibility of the services, what in-
formation they wanted to keep and what could be
improved. In this particular example, managers were
also later involved. The regulator used this information
in the assessment of the service provider.
Our synthesis found that user panels and user advisory
groups were common in the regulatory bodies across
countries. In England, the CQC has user panels to
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provide input and advice regarding the regulation of
children and mental healthcare services. In Norway, the
NBHS recently established a user panel at the national
level to inform all regulatory activity. Several Norwegian
regional regulatory offices have established user panels.
The Dutch inspectorate organizes user panels on specific
regulatory topics and is investigating the possibility of a
structural user advisory board. Furthermore, the Dutch
inspectorate involved users in developing their multi an-
nual policy plan ‘20–23’, and the Youth Care department
of this inspectorate has been advised by a Children’s
Council in 2019. Similar methods that focus on involve-
ment in committees and panels are human research
ethic committees and clinical governance committees
which are established in Australia. In England, the CQC
commissioned research with users.
The regulators also collaborated and organized semi-
nars with user groups, councils, charities, and organiza-
tions to collect information and experiences as part of
the planning of inspection activities. Some of these activ-
ities were co-produced by the user organizations and the
regulatory bodies. We also found examples of organizing
co-investigator workshops to collect experiences and les-
sons learnt from the experts-by-experience who had
been involved in some kind of regulatory activity.
In this category, we also identified virtual involvement
initiatives and campaigns using social media, digital mar-
keting, and other online platforms to encourage patients
and families to share their knowledge and experiences
with the service providers. Other initiatives online re-
lated to disseminating general information to user
groups about the regulators’ role and responsibility. In
the Netherlands, the ratings and reviews of an independ-
ent patient rating website are used by inspectors to iden-
tify risks and themes for theme based regulation and to
prioritize their visits. The Dutch inspectorate also
searches social media for signals from users about the
quality of care in the health services they visit. Further-
more, we identified an English initiative where CQC had
established a public online community for involvement
in health policy and service design. This included both a
representative panel and self-selected groups. The CQC
additionally took advantage of a data sharing partnership
with other websites collecting intelligence from users
that is then used by the regulator.
The results show collective user involvement for pro-
active purposes in Australia in accreditation requiring
healthcare organizations to partner with consumers in
planning, designing, measuring, delivering and evaluat-
ing care. A final example in this category is the national
recommendations for user involvement in regulations in
Norway. Results from Norway suggest a large emphasis
on user involvement in regulation over the previous
four-year period (2014–2018), where the NBHS made a
strategic effort to improve user involvement in regula-
tion by different means, such as funding innovation pro-
jects to test new ways of approaching user involvement
in regulation. As a result of the four-year involvement
program, the NBHS developed national recommenda-
tions for user involvement in regulation. Lessons learnt
and strategic actions were summarized and the recom-
mendations related to methods, experiences, and how
regulators can and should involve users in their own
regulatory activities and their training of inspectors. The
recommendations underline patient and user involve-
ment as a core value for health service provision and for
regulatory bodies.
Collective reactive methods of involvement
This category relates to collective involvement after
healthcare has failed, in terms of adverse events or com-
plaints, but implies that it is not related to an individ-
ual’s own specific case. The collective reactive methods
repertoire was limited in all countries. Nevertheless, we
note some direct examples whereby the Dutch inspect-
orate aggregated the information from complaints col-
lected at the National Healthcare Report Centre by
sector and by theme. Also, the Dutch inspectorate per-
formed an explorative pilot on text mining the content
of the complaints for relevant topics. Similarly, in
England, the CQC analyses complaints and concerns
from various sources. This information is used as a
signal in risk-based regulation for agenda setting and
prioritization in both countries.
Reported benefits of involvement
The above synthesis shows the varied nature of user par-
ticipation in regulation in terms of the type of regulation
and the type of involvement. Not all the initiatives men-
tioned above have been evaluated. Evaluation practices
differ between countries. Comparatively, most practices
have been evaluated in the Netherlands where the in-
spectorate works with researchers in an academic collab-
orative. The practices that have been evaluated do offer
important insights into the main reported benefits and
challenges of involvement practice.
First, the primary espoused reason for involvement is
improving regulatory work, and by consequence improv-
ing the quality and safety of care [5, 16, 17, 32–47]. In
this view, patients and families are seen as an additional
information source. In case of incident investigations for
example, patients and families are able to put incidents
into a broader perspective and offer a more holistic un-
derstanding of what happened [13, 14, 16, 32, 33, 48].
The espoused reasons are similar for the input they pro-
vide during thematic inspections [17]. Similarly, experts-
by-experience can provide important knowledge as they
are more able to tap into experiences of patients,
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especially in the case of sensitive subjects such as alcohol
misuse amongst adolescents [12, 15, 49, 50]. Experts-by-
experience and related methods also offer another
view on quality of care by focusing more on relations
and ‘softer’ aspects of service provision (such as qual-
ity of the food, time spent outside, decorative aspects
of living facilities) rather than concentrating on safety
[15, 51–54]. Also, by analyzing reviews written on an
independent patient rating website and social media
posts, the regulator may identify risks from the pa-
tient’s perspective [35–37, 55–58].
Second, involvement is said to legitimize decision-
making of the regulator by using information gathered
from patients and the family in the regulatory assess-
ment, but also by co-producing inspection criteria [5, 6,
54]. This relates to the goal of democratic decision-
making. For example, when patients and the families
support the findings of the regulator this is added to
regulatory reports [6, 12, 54]. Patient and family involve-
ment is also related to being transparent about the work
of the regulator, and connecting with patients or the
public more generally improves the image of, or trust in,
the regulator [5, 13, 14, 48]. This argument is not only
used to support the active involvement of patients and
families, but also to send information through, for ex-
ample social media, about the work of the regulator to
the public [55, 56].
Third, involvement is a way of achieving justice for
those affected. This especially applies to the involvement
of patients and families during incident investigations as
shown in Norway, the Netherlands and Australia. Here
their involvement is a way of regaining trust and restor-
ing the therapeutic relationship, including the opportun-
ity to apologize [13, 14, 32, 48]. Moreover, involvement
allows for the provision of information to the patient
and family, as well as space to share emotions and pro-
vide aftercare [13, 14, 16, 32, 33, 40, 48, 59, 60]. Also,
some reports mentioned that through involvement escal-
ation of issues to legal claims could be avoided [16, 40].
The need for justice for those affected by poor care can
also be found in relation to other methods. For example,
in a case of conducting interviews with the elderly, it
was shown that participants appreciated the genuine
interest in their perspective and felt it was positive to be
heard [61]. This was also found in relation to involve-
ment of next of kin in the regulatory investigation of ad-
verse event when patients had died. Next of kin
expected to be involved and evaluation showed that in-
volvement could have a therapeutic effect [13]. The
regulatory inspectors in this case found involvement to
be in accordance with overall political expectation [14].
Fourth, involvement can be a way for users to em-
power themselves and learn new skills [12, 17, 41, 49,
50, 54]. For example, experts-by-experience learn a lot
about a specific subject (e.g., elderly care, alcohol mis-
use) and the work of the inspectorate [17, 49, 52].
Reported difficulties concerning participation
Along with the possible benefits reported above, the re-
sults also show a number of difficulties experienced by
regulators when putting involvement into practice. First,
it can prove difficult to incorporate the input of patients
and families into the decisions or reports of the regula-
tor [6, 15, 16, 32, 40, 48]. This has partly to do with the
perceived lack of legitimacy of patient or family input. It
was regularly argued that patients lack the necessary
knowledge to contribute, and less weight is given to their
input than, for instance, the input of professionals (e.g.,
in case of incident investigations, theme based inspec-
tions or experts-by-experience) [6, 12–14, 16, 32, 35, 48,
51]. As described earlier, the main argument for involve-
ment is that patients and families provide additional in-
formation. However, in cases of conflicting input (e.g.,
different views on what an incident is, what should be
the focus of the investigation or what should be consid-
ered good quality care) the contribution of patients and
family appears to be difficult to incorporate [6, 16, 48].
As a result, there is a danger that involvement becomes
tokenistic [44, 45]. A recent example from Dutch re-
search tackles this conflict by making the client perspec-
tive the starting point for regulation. Inspectors followed
the client’s perspective and judgements throughout the
whole inspection process [54]. However, possible con-
flicts are likely to persist, and the question remains “how
will inspectors make informed judgements in such cases
in order to do justice to the complexities of regulatory
practice”?
Second, not all patients or family members want to be
involved or are easy to involve. For example, in case of
incident investigations it has been reported that partici-
pation is too burdensome as the incident can have a
large impact on patients and families [16, 32, 33, 48]. In
other cases, it is difficult to do justice to the diversity of
patients, as some groups are more inclined to participate
than others. This leads to questions concerning the rep-
resentativeness of those involved and for whom they can
speak [5, 48]. This is also an important difficulty at-
tached to professionalization attempts of participants.
For example, experts-by-experience are often trained for
their task. This may ultimately diminish the value of the
authentic perspective that they can provide [12].
This leads us to the third difficulty we identified, that
participation involves time and costs [5, 13, 14, 33, 34,
40, 48, 54]. This is especially true for practices directed
at so-called ‘hard to reach’ groups because the regulator
must expend significant time and effort to come into
contact with them, and attune participation to their
needs. User participation in general is also expensive.
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For example, the CQC’s Experts By Experience program
has cost an average of £4 million annually in recent
years (CQC news). Inspectors in a pilot project in
Norway sometimes found it time consuming to involve
next of kin due to difficulties in scheduling meetings and
the need for additional follow up contacts to collect new
information from, for example, actors newly implicated
in contributing to the cause of an adverse event. Inspec-
tors did not recommend continuing this involvement
method unless it was compensated properly in the work
schedule and incorporated in the organization [48].
Fourth, organizational procedures can stand in the
way of involvement. This includes the language used by
inspectors, and is also due to certain protocols [6, 16,
32]. For example, incident investigations need to happen
in a specific timeframe, the deadline of which can be too
soon for the patients or family to be able to participate
[16, 32, 33]. Also, the regulatory context can prohibit
taking the input of patients on board. The case of youth
involvement in a thematic inspection on care for chil-
dren growing up poor by the Dutch inspectorate is a
case in point. The interviewed youths stated that they
felt their privacy was very important and therefore pro-
fessionals should not share information about them with
each other. In this case part of this conflict was influ-
enced by the regulatory context as policy makers and
regulators put much emphasis on sharing information in
response to fatal incidents, which were analyzed as
resulting from a lack of sharing information [6].
A final difficulty was identified as dealing with the
emotions of those involved. This not only applies to the
emotions of patients and family members, but of the
professionals and regulators themselves, who can also be
affected by participation. Emotions can be felt especially
keenly during incident investigations [13, 14, 16, 48]. For
the next of kin who have lost a close relative, it can be a
considerable mental strain to be part of the entire inves-
tigation process when they are grieving and sometimes
traumatized. The investigation process can repeatedly
remind them of the event leading to the death. However,
the interpersonal skills of the inspectors may help to re-
duce this emotional burden. From the inspectors’ point
of view, it can be emotionally challenging to involve next
of kin in investigation meetings, because the inspectors
can worry about attending beforehand and might con-
tinue to dwell on things after the meeting, especially in
severe cases. Some inspectors have a legal professional
background where they were not trained for face-to-face
meetings with people in grief, as inspectors with a
healthcare background may have been. At the same
time, inspectors report that it is a positive experience to
offer support to the next of kin and clarify any misun-
derstandings or questions [13, 14, 48]. In other cases
emotions can play a role as, for example, a project
involving mystery guests, where civil servants providing
services to people with learning disabilities reported feel-
ing left out as their perspective was not sufficiently taken
into account [54].
Discussion
Unpacking the landscape of user involvement in
regulation
As studies into patient and family involvement in regula-
tion are scarce (e.g., [5, 9]) one could question whether
regulatory bodies have been part of the general trend in
healthcare to involve patients and family members in
decision-making. Our study reveals that regulators are
very much part of this development. They are in fact
experimenting with a wide variety of user, patient, and
family involvement methods. Although the context, way
of organizing and regulatory environment varied by
country, and some regulators are experimenting more
intensively with involvement than others, we saw a var-
iety of methods in each of our cases. Regulators used
methods in all four categories identified in the paper.
The study shows that the benefits of involvement are
multi-faceted. Reported advantages from the published
empirical research include for example increased quality
of regulatory practice – because it is informed by the
unique experiences and insight of people who use care
services. Moreover, patient and family involvement in-
creased legitimacy, empowerment, and contributed to
justice done to those affected by adverse events (see also
[13, 14, 54]). We thus found that involvement can serve
multiple purposes – such as in strengthening the quality
of regulatory practice, and being beneficial for the users,
patients and families involved [13, 14]. In addition, in-
volvement can be used as an instrument to prevent fur-
ther escalation of problems, through formal regulatory
investigation processes or legal claims [11, 16].
Despite this reported added value, our study also iden-
tified challenges of user involvement in regulation. It is
not easy to develop a regulatory culture where involve-
ment is meant to be integrated into work practice. Also,
it is not clear how to use information from experts-by-
experience. This is especially important if involvement is
conducted to comply with political expectations and not
as a way of improving the quality of regulatory activities
[40, 62]. In many cases, information provided by users
introduces an additional, and different, perspective, but
this also means that it can clash with the perspective of,
for instance, professionals or regulators [6, 16, 48, 63].
Our findings suggest that the input from users has
sometimes been put aside by questioning its legitimacy.
If this happens, it equates to epistemic injustice [64, 65]
– especially if the knowledge base of users, patients, and
family members is considered of less value than those of
other actors. This can clearly occur if these extra
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perspectives do not fit with longstanding regulatory pro-
cedures, or with views held strongly by professionals,
managers and regulators [66–68].
Other challenges include that not all patients and fam-
ily members want to be involved, involvement costs time
and money, and it can pose an emotional burden on
those involved (see also [13, 14, 69]). The emotional bur-
den is especially pertinent to the individual reactive in-
volvement category discussed above [5, 13, 14]. If user
involvement in regulation is a question of morality or
logic [8] then how regulators deal with the challenge of
emotionality, or epistemic injustice [64], should be fur-
ther investigated to understand the rationale and experi-
ences of regulatory bodies.
There are a number of lessons for regulatory practice.
A clear lesson is to target involvement activities and to
take advantage of existing opportunities [5, 6, 54]. Since
participation is time-consuming for all involved, it is im-
portant to consider for which situations it is most im-
portant, and to identify the best ways to go about it. The
case of using mystery guests with learning disabilities in
the Netherlands is a good example in this regard [17,
54]. The mystery guests were asked to assess the access
to municipal services for people with learning disabil-
ities, an assessment which can only be adequately made
through experience.
There are also ways to include users, patient, and fam-
ily perspectives based on existing information which can
be exploited [5]. Examples of such involvement are 1) to
use social media as a way to trace problems in health-
care, 2) to aggregate information from patient com-
plaints, or 3) to perform text mining from patient
complaints to search for new types of risks and topics
for future inspections [35–38, 57, 58, 70–72]. While
uniquely representing quality of care from a patient’s
point of view, however, this requires further reflection
on methodological issues such as the reliability and val-
idity of these (public) resources.
Another lesson is that involvement needs an embed-
ding strategy. Regulators should think about how to sup-
port involvement in their activities, including valuing the
financial and time investments [69]. There is also a need
to train inspectors such that they can reflect on how to
judge different perspectives on quality and how to deal
with the emotional burden that can accompany involved
users [13, 14]. Good judgement on how and when to in-
corporate the input of patients is also needed, if that in-
put is to be productive. This might warrant changes in
procedures and regulatory frameworks as patients and
regulators can have different values and perspectives
(e.g., what counts as an incident, how quality of care
should be judged) [6, 16, 54, 63]. In this regard, it should
be emphasized that participation on its own does not ne-
cessarily lead to increased patient-centeredness or
learning [2, 32]. An important question to reflect on is
how to conduct training of users, patients, family mem-
bers, and inspectors to succeed with involvement in
regulation [12]. The danger is that such training may
lead to the professionalization of patient input, which
can distance the participants from their experiences as
patients [62]. This is problematic because tapping into
these experiences is often considered the most import-
ant reason for involvement [2, 73].
Finally, it is important to make participation user-
friendly and to ensure inclusiveness. In England, much
effort is used in making forms and websites accessible,
and in building relationships and trust with people from
vulnerable groups. Our findings indicate that involving
‘hard to reach’ groups might be challenging, but it can
be done [74]. All-in-all, further investigation is needed
to evaluate targeted involvement methods of hard to
reach groups.
Strengths and limitations
Several researchers participated in the data collection,
which made it possible to include information from vari-
ous countries and sources. This, however, may also have
created variation in data sources. This limitation was
moderated by using the template and having numerous
discussions between authors.
The regulatory regime is complex [74] and the avail-
able data in each country varied, especially in terms of
the number of published empirical studies. Most re-
search on involvement in regulation has been conducted
in the Dutch setting. We cannot be sure that this is a
complete mapping, since involvement methods can be
used in regulatory practice without being published or
even identified as ‘regulatory practice’. We used data
from different sources, such as internet websites, evalu-
ation reports, and peer reviewed papers. This broad ap-
proach was important in providing an overview of
methods available, in addition to documenting possible
advantages and disadvantages and lessons learnt that are
relevant to other regulators.
We categorized methods according to the proactive-
reactive and individual-collective dimensions inspired by
Tritter’s [1] published framework. We used the dimen-
sions as a heuristic tool to gain insight into the variety of
methods. Tritter’s [1] original work on reactive and pro-
active involvement distinguished between whether par-
ticipation is responding to a pre-existing agenda, in our
case set by a regulator (reactive), or if the participants
are helping to shape it (proactive). We have added to
this conceptualization by including: 1) if participants
have experienced an adverse event and responded ac-
cording to the regulators’ procedures for follow up (re-
active), or 2) if the participants have not experienced an
adverse event, but provide information to the regulator
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based on their experiences, to influence future regulatory
activities (proactive). On the one hand, this illustrates
the strengths, showing that with a few changes, Tritter’s
[1] framework may be broadly applicable, including in
the regulatory context. On the other hand, the slight de-
viance from the original version could be considered a
limitation.
We do not know whether the diversity we found in
methods relates to country characteristics, regulatory re-
gimes or other factors. Further studies might continue
investigations along these lines. Examining a number of
different countries with diverse regulation systems was a
strength as it enabled us to identify a variety of ways of
involving users. However, it also made it difficult to de-
termine to what extent differences in user involvement
were the result of the different countries’ regulatory
systems.
Conclusion
Our mapping of user involvement methods brought into
focus a broad variety of methods. These can serve as in-
spiration to regulators in healthcare. Based on our map-
ping exercise we suggest that future regulatory practice
continues to develop and pilot new types of user in-
volvement methods including individual and collective,
and proactive and reactive activities. The paper shows
that making involvement in regulation successful is a
challenging and complex task. Our findings suggest that
it is not easy to reach the goals of increased involvement
and democratic decision-making. The fact that regula-
tors are experimenting with different methods can be
valued positively in this regard. As a result, regulators
have room to innovate and evaluate work involving new
kinds of groups (e.g., older people, youths, people with
learning disabilities); new topics and areas of inspections
(e.g., social care, elderly care, care transition); different
degrees of involvement (e.g., involved in a meeting vs
part of inspection team during inspection processes);
and new ways of engaging with users and service
provision (e.g., mystery guests). Experimenting with
these methods means that lessons can be drawn to im-
prove involvement practices, such as how the perspec-
tive of users can be incorporated in the judgements that
regulators make or in accessing hard to reach groups.
For this, further research into these programs is
recommended.
Most research is seen in the Dutch context. However,
these studies suggest that the promotion of collaboration
between regulatory bodies and research groups to build
a network for research-based-regulation and regulation-
based-research, may help stimulate better research, regu-
lation, and educational programs for future regulators.
More international collaborations between researchers
and inspectorates could provide further impetus, for
instance via the European Partnership for Supervisory
Organisations in Health Services and Social Care (EPSO)
or the Supervision and regulation Innovation Network
for Care (SINC) that inspectorates from various coun-
tries established recently. Further development of similar
collaboration arenas should be stimulated. As the issue
of user involvement is high on the agenda of many regu-
lators, it underscores the importance of this collaborative
research agenda.
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